Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of AR115295A1publicationCriticalpatent/AR115295A1/es
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Uso de un anticuerpo de unión a IL-1b o un fragmento funcional del anticuerpo, especialmente canakinumab o su fragmento funcional, o gevokizumab o su fragmento funcional, y biomarcadores para el tratamiento y/o la prevención de un cáncer que tiene una base inflamatoria por lo menos parcial.
ARP190103804A2018-12-212019-12-20USO DE ANTICUERPOS QUE UNEN A IL-1b
AR115295A1
(es)